Filing Details
- Accession Number:
- 0001610717-24-000089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 18:30:54
- Reporting Period:
- 2024-02-20
- Accepted Time:
- 2024-02-22 18:30:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1611311 | P. David Rosenbaum | C/O Ardelyx, Inc. 400 Fifth Avenue, Suite 210 Waltham MA 02451 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-20 | 5,017 | $8.75 | 378,985 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-20 | 2,294 | $8.75 | 181,119 | No | 4 | S | Indirect | By Wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Wife |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 77,592 | Indirect | Family Trust |
Footnotes
- Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- The shares are directly held by the Reporting Person's wife.
- The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.